Epithelial cell adhesion molecule fragments and signaling in primary human liver cells

Jörg C. Gerlach, Hubert G. Foka, Robert L. Thompson, Bruno Gridelli, Eva Schmelzer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Epithelial Cell Adhesion Molecule (EpCAM), or CD326, is a trans-membrane glycoprotein expressed by multiple normal epithelia as well as carcinoma. Human hepatic stem cells and bile duct epithelium of the liver are EpCAM positive. In tumor cell lines, its intracellular domain can be released after cleavage of the extracellular domain. Within the cell nucleus, it induces cell proliferation, but cleavage depends on cell contact. Fragments of various lengths have been described in tumor cells. Despite its described important role in proliferation in tumor cells, there is not much known about the expression and role of EpCAM fragments in primary human liver cells. Here, we demonstrate that EpCAM protein fragments and function are considerable different between tumor cells, normal fetal and adult liver cells. Contrary to previously reported findings in tumor cells, gene knockdown or treatment with an inhibitor of the cleavage enzyme ADAM17 (TACE) rather increased cell numbers in primary human fetal liver-derived EpCAM-positive cells. EpCAM fragment sizes were not affected by treatment with inhibitor. Knockdown of EPCAM gene expression by siRNA in sorted cells did not significantly affect proliferation-associated genes or cell numbers. The intracellular domain could not be detected within cell nuclei of fetal and adult liver cells. In conclusion, signaling through the intracellular domain of EpCAM appears to be a mechanism that induces proliferation specifically in tumorigenic cells but not in normal primary EpCAM-positive liver cells.

Original languageEnglish
JournalJournal of Cellular Physiology
DOIs
Publication statusE-pub ahead of print - Dec 26 2017

Fingerprint

Cell Adhesion Molecules
Liver
Cells
Tumors
Genes
Cell Nucleus
Epithelial Cells
Epithelial Cell Adhesion Molecule
Neoplasms
Membrane Glycoproteins
Cell proliferation
Epithelium
Cell Count
Stem cells
Gene expression
Ducts
Small Interfering RNA
Gene Knockdown Techniques
Enzyme Inhibitors
Cadherins

Keywords

  • CD326
  • EpCAM
  • Hepatocyte
  • Liver
  • Progenitor
  • Stem cell

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Epithelial cell adhesion molecule fragments and signaling in primary human liver cells. / Gerlach, Jörg C.; Foka, Hubert G.; Thompson, Robert L.; Gridelli, Bruno; Schmelzer, Eva.

In: Journal of Cellular Physiology, 26.12.2017.

Research output: Contribution to journalArticle

Gerlach, Jörg C. ; Foka, Hubert G. ; Thompson, Robert L. ; Gridelli, Bruno ; Schmelzer, Eva. / Epithelial cell adhesion molecule fragments and signaling in primary human liver cells. In: Journal of Cellular Physiology. 2017.
@article{8aba8ca13d854588a5adc23b0d89e57b,
title = "Epithelial cell adhesion molecule fragments and signaling in primary human liver cells",
abstract = "Epithelial Cell Adhesion Molecule (EpCAM), or CD326, is a trans-membrane glycoprotein expressed by multiple normal epithelia as well as carcinoma. Human hepatic stem cells and bile duct epithelium of the liver are EpCAM positive. In tumor cell lines, its intracellular domain can be released after cleavage of the extracellular domain. Within the cell nucleus, it induces cell proliferation, but cleavage depends on cell contact. Fragments of various lengths have been described in tumor cells. Despite its described important role in proliferation in tumor cells, there is not much known about the expression and role of EpCAM fragments in primary human liver cells. Here, we demonstrate that EpCAM protein fragments and function are considerable different between tumor cells, normal fetal and adult liver cells. Contrary to previously reported findings in tumor cells, gene knockdown or treatment with an inhibitor of the cleavage enzyme ADAM17 (TACE) rather increased cell numbers in primary human fetal liver-derived EpCAM-positive cells. EpCAM fragment sizes were not affected by treatment with inhibitor. Knockdown of EPCAM gene expression by siRNA in sorted cells did not significantly affect proliferation-associated genes or cell numbers. The intracellular domain could not be detected within cell nuclei of fetal and adult liver cells. In conclusion, signaling through the intracellular domain of EpCAM appears to be a mechanism that induces proliferation specifically in tumorigenic cells but not in normal primary EpCAM-positive liver cells.",
keywords = "CD326, EpCAM, Hepatocyte, Liver, Progenitor, Stem cell",
author = "Gerlach, {J{\"o}rg C.} and Foka, {Hubert G.} and Thompson, {Robert L.} and Bruno Gridelli and Eva Schmelzer",
year = "2017",
month = "12",
day = "26",
doi = "10.1002/jcp.26286",
language = "English",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Epithelial cell adhesion molecule fragments and signaling in primary human liver cells

AU - Gerlach, Jörg C.

AU - Foka, Hubert G.

AU - Thompson, Robert L.

AU - Gridelli, Bruno

AU - Schmelzer, Eva

PY - 2017/12/26

Y1 - 2017/12/26

N2 - Epithelial Cell Adhesion Molecule (EpCAM), or CD326, is a trans-membrane glycoprotein expressed by multiple normal epithelia as well as carcinoma. Human hepatic stem cells and bile duct epithelium of the liver are EpCAM positive. In tumor cell lines, its intracellular domain can be released after cleavage of the extracellular domain. Within the cell nucleus, it induces cell proliferation, but cleavage depends on cell contact. Fragments of various lengths have been described in tumor cells. Despite its described important role in proliferation in tumor cells, there is not much known about the expression and role of EpCAM fragments in primary human liver cells. Here, we demonstrate that EpCAM protein fragments and function are considerable different between tumor cells, normal fetal and adult liver cells. Contrary to previously reported findings in tumor cells, gene knockdown or treatment with an inhibitor of the cleavage enzyme ADAM17 (TACE) rather increased cell numbers in primary human fetal liver-derived EpCAM-positive cells. EpCAM fragment sizes were not affected by treatment with inhibitor. Knockdown of EPCAM gene expression by siRNA in sorted cells did not significantly affect proliferation-associated genes or cell numbers. The intracellular domain could not be detected within cell nuclei of fetal and adult liver cells. In conclusion, signaling through the intracellular domain of EpCAM appears to be a mechanism that induces proliferation specifically in tumorigenic cells but not in normal primary EpCAM-positive liver cells.

AB - Epithelial Cell Adhesion Molecule (EpCAM), or CD326, is a trans-membrane glycoprotein expressed by multiple normal epithelia as well as carcinoma. Human hepatic stem cells and bile duct epithelium of the liver are EpCAM positive. In tumor cell lines, its intracellular domain can be released after cleavage of the extracellular domain. Within the cell nucleus, it induces cell proliferation, but cleavage depends on cell contact. Fragments of various lengths have been described in tumor cells. Despite its described important role in proliferation in tumor cells, there is not much known about the expression and role of EpCAM fragments in primary human liver cells. Here, we demonstrate that EpCAM protein fragments and function are considerable different between tumor cells, normal fetal and adult liver cells. Contrary to previously reported findings in tumor cells, gene knockdown or treatment with an inhibitor of the cleavage enzyme ADAM17 (TACE) rather increased cell numbers in primary human fetal liver-derived EpCAM-positive cells. EpCAM fragment sizes were not affected by treatment with inhibitor. Knockdown of EPCAM gene expression by siRNA in sorted cells did not significantly affect proliferation-associated genes or cell numbers. The intracellular domain could not be detected within cell nuclei of fetal and adult liver cells. In conclusion, signaling through the intracellular domain of EpCAM appears to be a mechanism that induces proliferation specifically in tumorigenic cells but not in normal primary EpCAM-positive liver cells.

KW - CD326

KW - EpCAM

KW - Hepatocyte

KW - Liver

KW - Progenitor

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=85039171940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039171940&partnerID=8YFLogxK

U2 - 10.1002/jcp.26286

DO - 10.1002/jcp.26286

M3 - Article

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

ER -